Cannara Biotech Inc. (TSXV:LOVE)

Market Cap	162.75M
Revenue (ttm)	101.87M
Net Income (ttm)	15.52M
Shares Out	91.43M
EPS (ttm)	0.17
PE Ratio	10.48
Forward PE	17.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,908
Average Volume	48,239
Open	1.750
Previous Close	1.780
Day's Range	1.720 - 1.780
52-Week Range	0.570 - 1.990
Beta	0.26
RSI	48.79
Earnings Date	Oct 21, 2025

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Employees: 13
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: LOVE

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.